Periampullary cancers: Are there differences?

Surgical Clinics of North America

Volumn 81, Issue 3, 2001, Pages 543-555

  Sarmiento, Juan M ^b   Nagorney, David M ^b   Sarr, Michael G ^b   Farnell, Michael B ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT; BILE DUCT CANCER; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; DUODENUM CANCER; HUMAN; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; SURGICAL TECHNIQUE; VATER PAPILLA;

EID: 0034973988     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70142-0     Document Type: Conference Paper

References (71)

1. Pancreatoduodenectomy for periampullary adenocarcinoma
2. Embryologic and anatomic basis of duodenal surgery
3. Morphogenesis and possible precursor lesions of invasive carcinoma of the ampulla of Vater
4. What prognostic factors are important in duodenal adenocarcinoma?
5. Tumor of the ampulla of Vater
6. Clinicopathologic study for the assessment of resection for ampullary carcinoma
7. Factors influencing survival after pancreatoduodenectomy for pancreatic cancer
8. Diagnosis and therapy of ampullary tumors
9. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection
10. Carcinoma of the ampulla of Vater: Prognostic factors after curative surgery: A series of 45 cases
11. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumors
12. Villous tumors of the duodenum: Reappraisal of local vs. extended resection
13. Locoregional dissemination and extended lymphadenectomy in pancreatic cancer
14. Outcome of treatment for distal bile duct cancer
15. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy
16. Growth factor receptors are differently expressed in cancers of the papilla of Vater and pancreas
17. Surgical treatment of ductal pancreatic carcinoma
18. Prognostic indicators of survival after resection of pancreatic adenocarcinoma
19. Adjuvant therapy for pancreatic cancer
20. Pancreatic invasion is a prognostic indicator after radical resection for carcinoma of the ampulla of Vater
21. Role of nodal involvement and the periductal soft tissue margin in middle and distal bile duct cancer
22. Lymphatic flow in carcinoma of the distal bile duct based on clinicopathological study
23. Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis on nodal involvement and plexus invasion
24. Is local excision of pT1-ampullary carcinomas justified?
25. Carcinoma of the ampulla of Vater: Determinants of long-term survival in 94 resected patients
26. Carcinoma of the pancreas and periampullary region: Palliation versus cure
27. Cancer of the ampulla of Vater
28. The mode of lymphatic spread in carcinoma of the bile duct
29. The case for parallel classification of biliary tract and pancreatic neoplasms
30. Radical resection for carcinoma of the ampulla of Vater
31. Long-term survival in pancreatic cancer: Pylorus-preserving versus Whipple pancreatoduodenectomy
32. Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas
33. A clinical study on lymphatic flow in carcinoma of the pancreatic head area-peripancreatic regional lymph node grouping
34. Outcomes after curative resections of cholangiocarcinoma
35. Importance of microperineural invasion as a prognostic factor in ampullary carcinoma
36. Lymph node metastases in carcinoma of the head of the pancreas region
37. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors
38. Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: U.K. survey of specialist pancreatic units
39. Long-term survival after resection for ductal adenocarcinoma of the pancreas: Is it really improving?
40. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenectomy plus extended lymphadenectomy
41. Effectiveness of multimodality treatment for respectable pancreatic cancer
42. Adenomas of the small intestine: A clinicopathologic review of 51 cases and a study of their relationship to carcinoma
43. Node-positive duodenal carcinoma is curable
44. Defining the criteria for local resection of ampullary neoplasms
45. Pancreatoduodenectomy for ampullary carcinoma
46. Pylorus-preserving versus standard pancreatoduodenectomy: An analysis of 110 pancreatic and periampullary carcinomas
47. Primary duodenal adenocarcinoma: A ten-year experience with 79 patients
48. Villous tumors of the duodenum
49. Adenocarcinoma of the duodenum
50. Incidence and treatment of periampullary duodenal cancer in the U.S. Veteran population
51. Patterns of lymphatic spread of carcinoma of the ampulla of Vater
52. Carcinoma of the ampulla of Vater: Is radical lymphadenectomy beneficial to patients with nodal disease?
53. Adenocarcinoma of the duodenum: Factors influencing long-term survival
54. Survival after resection for ductal adenocarcinoma of the pancreas
55. Primary adenocarcinoma of the duodenum
56. Factors affecting morbidity, mortality, and survival after pancreatoduodenectomy for carcinoma of the ampulla of Vater
57. Liver metastases after curative resection in patients with distal bile duct cancer
58. Preservation of the pylorus in pancreatoduodenectomy
59. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation?
60. The Whipple resection for cancer in U.S. Department of Veteran Affairs Hospitals
61. Experience with distal bile duct cancers in U.S. Veterans Affairs Hospitals
62. Treatment of carcinoma of the ampulla of Vater
63. Patterns of failure after pancreatoduodenectomy for ampullary carcinoma
64. Pancreatoduodenal carcinoma: A clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA 19-9
65. Carcinoma of the ampulla of Vater: A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma
66. Pancreatoduodenectomy for cancer of the head of the pancreas: 201 Patients
67. Six hundred fifty consecutive pancreatoduodenectomies in the 1990s: Pathology, complications, and outcomes
68. Periampullary adenocarcinoma. Analysis of 5-year survivors
69. Patterns of node metastasis in carcinoma of the distal bile duct
70. Clinical presentation, diagnosis, and survival of resected distal bile duct cancer
71. Adenocarcinoma of the duodenum and ampulla of Vater: Clinicopathology study and expression of p53, c-neu, TGF, CEA, and EMA